Postscripts from the Post-Coronary Artery Bypass Graft trial: the sustained benefit of more aggressive cholesterol lowering and the enigma of low-dose anticoagulation.
Waters
D D
DD
Azar
R R
RR
D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D000925:Anticoagulants / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D006801:Humans
D000924:Anticholesteremic Agents; D000925:Anticoagulants